Showing results (641-650 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|March 7, 2013
Population pharmacokinetic analysis of clopidogrel in healthy Jordanian subjects with emphasis optimal sampling strategyA M Yousef, M Melhem, B Xue, et al.Biopharmaceutics & Drug Disposition|July 23, 2013
Assessment of CYP3A-mediated drug-drug interaction potential for victim drugs using an in vivo rat modelNathalie Rioux, Edith Bellavance, Serge Bourg, et al.Biopharmaceutics & Drug Disposition|October 1, 1990
Bioavailability and cardiovascular safety of Dexatrim (phenylpropanolamine hydrochloride) from a controlled-release capletL Shargel, H I Silverman, P Cohen, et al.Biopharmaceutics & Drug Disposition|May 15, 2012
Identification of human cytochrome P450 enzymes involved in the metabolism of a novel к-opioid receptor agonist, nalfurafine hydrochlorideAkihiro Ando, Keiyu Oshida, Shinichi Fukuyama, et al.Biopharmaceutics & Drug Disposition|August 1, 1992
Influence of probenecid and paracetamol (acetaminophen) on zidovudine glucuronidation in human liver in vitroF Kamali, M D RawlinsBiopharmaceutics & Drug Disposition|August 1, 1992
Pharmacokinetics and metabolism of codeine in humansT B Vree, C P Verwey-van WissenBiopharmaceutics & Drug Disposition|March 14, 2002
Development and validation of a non-linear IVIVC model for a diltiazem extended release formulationNattee Sirisuth, Larry L Augsburger, Natalie D EddingtonBiopharmaceutics & Drug Disposition|October 1, 1983
Measurement of plasma concentrations of vasodilators and metabolites by the TEA AnalyzerW C Yu, E U GoffBiopharmaceutics & Drug Disposition|July 1, 1993
Bioequivalence study of nalidixic acid tablets: in vitro-in vivo correlationH Jung, H Gonzalez, J M RodriguezBiopharmaceutics & Drug Disposition|July 1, 1993
Relative bioavailability of two disopyramide capsules in humans based on total, unbound, and unbound enantiomer concentrationsH Takahashi, H Ogata, M Shimizu, et al.Pageof 214